Published in

Begell House, Critical Reviews in Immunology, 5(39), p. 379-408, 2019

DOI: 10.1615/critrevimmunol.2020033340

Links

Tools

Export citation

Search in Google Scholar

New Clinical Approaches and Emerging Evidence on Immune-Checkpoint Inhibitors as Anti-Cancer Therapeutics: CTLA-4 and PD-1 Pathways and Beyond

Journal article published in 2019 by Maria-Ioanna Christodoulou ORCID, Apostolos Zaravinos
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO